|
DCUN1D5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.72784009322413E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.66264787995851E-12 |
| Normal-vs-Stage2 |
1.52817999999888E-05 |
| Normal-vs-Stage3 |
1.28060007043018E-10 |
| Normal-vs-Stage4 |
4.24219548378346E-11 |
| Stage1-vs-Stage2 |
9.701200E-01 |
| Stage1-vs-Stage3 |
3.036800E-01 |
| Stage1-vs-Stage4 |
7.977000E-03 |
| Stage2-vs-Stage3 |
5.160200E-01 |
| Stage2-vs-Stage4 |
7.739900E-02 |
| Stage3-vs-Stage4 |
1.111350E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.24789067967868E-12 |
| Normal-vs-AfricanAmerican |
3.301699999958E-06 |
| Normal-vs-Asian |
5.73739999953915E-08 |
| Caucasian-vs-AfricanAmerican |
8.865200E-01 |
| Caucasian-vs-Asian |
5.263200E-01 |
| AfricanAmerican-vs-Asian |
7.674200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.75823849608059E-13 |
| Normal-vs-Female |
5.34738919810707E-12 |
| Male-vs-Female |
2.318200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.4240948378399E-11 |
| Normal-vs-Age(41-60Yrs) |
3.98903132747819E-13 |
| Normal-vs-Age(61-80Yrs) |
2.47179998691394E-09 |
| Normal-vs-Age(81-100Yrs) |
7.873600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.818300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.113600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.738000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.300600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.159010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.055800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.242600E-01 |
| Classical-VS-Follicular |
7.317000E-01 |
| Classical-VS-Other |
5.732600E-01 |
| Classical-VS-Normal |
1.66344715779587E-12 |
| Tall-VS-Follicular |
9.571000E-01 |
| Tall-VS-Other |
6.010000E-01 |
| Tall-VS-Normal |
2.72059999995022E-06 |
| Follicular-VS-Other |
5.788800E-01 |
| Follicular-VS-Normal |
5.14010000118859E-08 |
| Other-VS-Normal |
1.342410E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.63618074223405E-12 |
| Normal-vs-N1 |
8.7193996467505E-10 |
| N0-vs-N1 |
1.771050E-01 |
|
|
